People · Operator
Named in public records as an officer, director or promoter · active 2008–2020 · Manufacturing, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amyris, Inc. | — | Manufacturing | Series D+ | $1.6B | $77.1M | 2008 |
| Neumora Therapeutics, Inc. | — | Biotechnology | Growth/Late | $474.4M | $19.0B | 2020 |
Tamara Tompkins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Tamara Tompkins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samir Kaul | 1 | 32 |
| Robert Nelsen | 1 | 22 |
| Kristina Burow | 1 | 16 |
| JOHN DOERR | 1 | 14 |
| Geoff Duyk | 1 | 5 |
| L. John Doerr | 1 | 4 |
| Stacie Weninger | 1 | 4 |
| Matthew Fust | 1 | 4 |
| Neil Renninger | 1 | 4 |
| Philippe Boisseau | 1 | 3 |
| Patrick Pichette | 1 | 3 |
| John Melo | 1 | 3 |
| Paul Berns | 1 | 3 |
| Ralph Alexander | 1 | 2 |
| Jeryl Hilleman | 1 | 2 |
| R NEIL WILLIAMS | 1 | 2 |
| GEOFFREY DUYK | 1 | 2 |
| Peter Boynton | 1 | 2 |
| Fernando De Castro Reinach | 1 | 2 |
| Carole Piwnica | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.